CPT1A and acute myeloid leukemia: Inhibiting carnitine palmitoyltransferase 1a (CPT1a), the rate-limiting enzyme of the essential step of FAO, enhances the antileukemic activity of Bcl-2 inhibitor in AML (77, 78).